MPWT
JSPR icon

MassMutual Private Wealth & Trust’s Jasper Therapeutics JSPR Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-145
Closed -$805 – 2421
2025
Q2 		$805 Buy
+145
New +$714 ﹤0.01% 2161

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

MassMutual Private Wealth & Trust's JSPR Position: Q3 2025 in Review

MassMutual Private Wealth & Trust sold out of Jasper Therapeutics (JSPR) in Q3 2025, closing a stake of 145 shares — an estimated $805 sold.

MassMutual Private Wealth & Trust first reported a position in JSPR in Q2 2025 and held it in 1 quarter. The position peaked at $805 in Q2 2025. 60 funds tracked by Wall St. Rank hold JSPR as of Q3 2025.

  • MassMutual Private Wealth & Trust reported no remaining Jasper Therapeutics position as of Q3 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 145 Jasper Therapeutics shares in Q3 2025, an estimated $805.
  • MassMutual Private Wealth & Trust first reported a position in Jasper Therapeutics in Q2 2025 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Jasper Therapeutics position peaked at $805 in Q2 2025.
  • 60 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2025, filed 22 Oct 2025.